Evaluation of the efficacy of surgical treatment of cataracts in patients with neovascular age-related macular degeneration

QR Code

Evaluation of the efficacy of surgical treatment of cataracts in patients with neovascular age-related macular degeneration

Purpose. To study of the effectiveness of cataract surgery based on the results of a comprehensive evaluation, including the patient's opinion about the state of visual functions, when assessed using a questionnaire before and after surgery.Material and methods. 117 patients (117 eyes) diagnose...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. Zh. Fursova, E. I. Dmitrieva, M. A. Vasil’eva, A. S. Derbeneva, Yu. A. Karlash, I. F. Nikulich, A. A. Atamanenko, M. S. Tarasov
Format:	Article
Language:	Russian
Published:	Real Time Ltd 2024-12-01
Series:	Российский офтальмологический журнал
Subjects:	neovascular age-related macular degeneration cataract phacoemulsification questionary patients satisfaction
Online Access:	https://roj.igb.ru/jour/article/view/1623
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comprehensive evaluation of cataract phacoemulsification surgery efficacy in patients with neovascular age-related macular degeneration treated by of antiangiogenic drugs
by: A. Zh. Fursova, et al.
Published: (2025-07-01)

Cataract surgery in patients with age-related macular degeneration: questions and controversies
by: E. I. Dmitrieva, et al.
Published: (2022-03-01)

Risk Factor of Neovascular Agerelated Macular Degeneration Progression after Cataract Surgery
by: V. G. Likhvantseva, et al.
Published: (2024-04-01)

Clinical Evaluation of the Effectiveness of Neovascular Age-related Macular Degeneration Combined Treatment
by: L. A. Golota, et al.
Published: (2025-03-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

Structural and Functional Criteria of Neuroprotection Effectiveness after Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration
by: N. S. Zhajvoronok, et al.
Published: (2019-12-01)

Choroidal neovascularization activity and structure by optical coherence tomography angiography in age related macular degeneration
by: M. A. Kovalevskaya, et al.
Published: (2021-12-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Clinical, functional and aberrometric parallels in the treatment of the neovascular form of age-related macular degeneration
by: M. M. Magomedova, et al.
Published: (2024-07-01)

Quantitative characterization of types 1 and 2 macular neovascularization in neovascular age-related macular degeneration with intravitreal conbercept: an analysis utilizing optical coherence tomography angiography
by: Yan-Mei Shi, et al.
Published: (2025-08-01)

Implantation of the First IMT Macular Lens in Age-Related Macular Degeneration (Literature Review)
by: M. M. Bikbov, et al.
Published: (2019-08-01)

Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice
by: R. R. Fayzrakhmanov
Published: (2019-06-01)

Cataract surgery in patients with diabetes mellitus. Prevention and optimisation of the diabetic macular edema therapy
by: A. Zh. Fursova, et al.
Published: (2024-03-01)

Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration
by: F. A. Bakhritdinova, et al.
Published: (2018-10-01)

Preferences of Hospital Pharmacists for the Different Attributes of Intravitreal Treatments for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Spain: The SEEKING Study
by: José Luis Poveda, et al.
Published: (2025-05-01)

Short-term Outcomes of Anti-VEGF therapy in Neovascular Age-related Macular Degeneration with Initially Low Visual Acuity
by: A. N. Kulikov, et al.
Published: (2025-03-01)

Safety and effectiveness of brolucizumab in patients with neovascular age-related macular degeneration: A phase IV study from India
by: Asim K Ghosh, et al.
Published: (2025-06-01)

Early Real-World Outcomes of Switching to 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom
by: Muiz Musadiq, et al.
Published: (2025-06-01)

Real-world outcomes and treatment patterns in Colombian patients with neovascular age-related macular degeneration and diabetic macular edema
by: Joshua Kock, et al.
Published: (2025-06-01)

RGD-Functionalized Ginsenoside Rg3 Liposomes for Alleviating Oxidative Stress and Choroidal Neovascularization in Age-Related Macular Degeneration
by: Zhou J, et al.
Published: (2025-06-01)

Optical coherence tomography angiography for choroidal neovascularization in pathological myopia and neovascular age-related macular degeneration in combination with axial myopia in comparative analysis
by: E. A. Drozdova, et al.
Published: (2021-12-01)

Myopia and age-related macular degeneration: structural and anatomical changes of the eye
by: I. B. Alekseev, et al.
Published: (2019-08-01)

Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Aljuhani HS, et al.
Published: (2025-06-01)

Postoperative, or pseudophakic, macular edema
by: I. E. Ioshin
Published: (2020-12-01)

Features of Phacoemulsification in Macular Pathology. Part 1. Diagnostic Aspects
by: Yusef Naim Yusef, et al.
Published: (2021-10-01)

PROLONGED THERAPY WET FORM OF AGE-RELATED MACULAR DEGENERATION BY THE INTRODUCTION OF BEVACIZUMAB ON THE VISCOUS MEDIA IN SUBTENON SPACE (PRELIMINARY RESULTS)
by: A. N. Epihin, et al.
Published: (2014-06-01)

Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
by: M. V. Budzinskaya, et al.
Published: (2023-01-01)

Pathogenetic issues of retinal dystrophies associated with myopia and agerelated macular degeneration
by: I. B. Alekseev, et al.
Published: (2018-10-01)

THE FIRST EXPERIENCE OF USING ANTI-VEGF THERAPY PRIOR TO CATARACT SURGERY IN PATIENTS WITH DIABETIC MACULAR EDEMA
by: N. A. Malysheva
Published: (2018-10-01)

COMPARISON OF CLINICAL AND REAL-LIFE TRiaLS OF THE EFFECTIVENESS OF ANTI-VEGF THERAPY FOR age-related macular degeneration
by: M. V. Budzinskaya, et al.
Published: (2019-02-01)

Efficacy of aflibercept in patients with neovascular age-related macular degeneration when combined with cataract surgery
by: A. A. Kuznetsov, et al.
Published: (2018-10-01)

Long-term outcomes of drusenoid retinal pigment epithelium detachment in eyes with age-related macular degeneration
by: Sinem Karabulut, et al.
Published: (2025-06-01)

Screening of cytokines in blood serum and lacrimal liquid in wet and atrophic forms of age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2022-03-01)

Intraocular correction of presbyopia in cataract surgery
by: A. Zh. Fursova, et al.
Published: (2024-10-01)

The first Russian register of patients with neovascular age-related macular degeneration: a real-world clinical study
by: V. V. Neroev, et al.
Published: (2023-12-01)

An integrated analysis of clinical and morphometric indications of atrophic forms of age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2022-01-01)

AGE- MACULAR DEGENERATION AND GLAUCOMA. EPIDEMIOLOGICAL AND CLINIC-PATHOGENETIC ASPECTS
by: A. Z. Fursova, et al.
Published: (2019-02-01)

Clinical Phenotypes of Patients with Neovascular Age-Related Macular Degeneration and Poor Response to Aflibercept Treatment
by: V. G. Likhvantseva, et al.
Published: (2022-10-01)

Effect of vascular endothelial growth factor inhibitors on choroid in patients with macular choroid neovascular membrane and degenerative myopia . Preliminary report
by: V. A. Solomin, et al.
Published: (2014-07-01)

Mixed (combined) phenotype of the late stage of age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2021-06-01)